Posted on October 20, 2009

‘Superobesity’ associated with increased risk for death following bariatric surgery

Print Print Email Email Discuss in our forum Discuss in our forum

Veterans classified as superobese and those with higher chronic disease burden appear more likely to die within one year following bariatric surgery, according to a new report in Archives of Surgery.

The number of bariatric procedures performed in Veterans Affairs medical facilities more than tripled from 2000 to 2006; however, bariatric surgery is only performed on about 0.1% of all veterans who meet BMI criteria, according to background information.

Researchers examined patient factors associated with mortality among 856 obese veterans who underwent bariatric surgery in 12 VA bariatric surgeries from 2000 to 2006. Patients were, on average, aged 54 years, had an average BMI of 48.7 and 73% were men.

During follow-up, 6.3% of patients died; 1.3% died 30 days after surgery, 2.1% died 90 days after surgery and 3.4% died after one year.

Effects of superobesity

Statistical models revealed that patients classified as superobese, with a BMI ≥50 (36% of cohort), and those with a higher score on a measure of costs related to co-occurring disease (8% of cohort) had an increased risk for death.

Superobese patients accounted for 30 deaths in the overall cohort. The death rate after 30 days was 2%, after 90 days was 3.6% and after one year was 5.2%. Rates increased with higher comorbidity cost scores: 1.5% after 30 days; 5.8% after 90 days; 10.1% after one year.

The researchers cited several explanations for the increased risk for death among superobese patients, including increased difficulty of bariatric surgeries because of extra abdominal fat; greater risk for wound complications and blood clotting; and more obesity-related illnesses.

“These findings suggest that the risks of bariatric surgery in patients with significant comorbidities, such as congestive heart failure, complicated diabetes and chronic obstructive pulmonary disease, should be carefully weighed against potential benefits in older male patients and those with superobesity,” the researchers wrote.

In an accompanying editorial, Clifford W. Deveney, MD, from the department of surgery at Oregon Health and Sciences University, Portland, acknowledged that there is a group of patients, particularly older men with high morbidity scores, who may not see a survival advantage following bariatric surgery.

“Despite seeing increased mortality up to one year [in this study], others have demonstrated a clear survival benefit of bariatric surgery during five to 10 years, with survival advantage beginning at six months after surgery,” Deveney wrote. “Therefore, despite the fact that the mortality rate increases during the postoperative period up to one year, it is small and does not negate the several advantages for patients who undergo bariatric surgery.” – by Katie Kalvaitis

Arterburn D. Arch Surg. 2009;144:914-920.

More In the Journals summaries>>



There are no comments for this article. Be the first to comment.

Your comment

Name:
Comments:

EndocrineToday.com is intended for physician use. All comments will be posted at the discretion of the editors. We reserve the right not to post any comments with unsolicited information about drugs or other products, and at no time will the EndocrineToday.com web site be used for medical advice to patients.